Buy 2F-Ketamine Pellets – 100mg

Product Overview

2F-Ketamine Pellets – 100mg contain 2-fluorodeschloroketamine (2-FDCK), systematically named 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one, positioned as a high-purity dissociative research reagent for method development, reference standards, and structural characterization in professional analytical laboratories. This ortho-fluorinated ketamine analog supports reproducible chromatographic and spectrometric investigations within the arylcyclohexylamine class. Each 100mg pellet is manufactured from ≥98% pure active material using pharmaceutical-grade excipients and compression technology, ensuring uniform disintegration and analytical reliability in validated research protocols.

Exclusively supplied for laboratory research applications, these pellets receive no formulation approval, stability testing, or positioning for pharmaceutical, diagnostic, therapeutic, or non-research deployment. The discrete 100mg unit dosage facilitates exact quantitative transfer for calibration standards preparation in controlled environments maintaining institutional quality systems. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Chemical Identity & Classification

2F-Ketamine (2-FDCK) is chemically designated as 2-(2-fluorophenyl)-2-(methylamino)cyclohexanone hydrochloride, with synonyms including 2-fluorodeschloroketamine, 2′-Fl-2-Oxo-PCM, and fluoroketamine across chemical registries. Classified as an arylcyclohexylamine dissociative analog—specifically a deschloro-ketamine derivative with ortho-fluoro substitution—it serves as an analytical reference standard.

Molecular formula C13H16FNO- HCl exhibits MW 257.73 g/mol; CAS 111982-50-4 (free base), 111982-49-1 (HCl salt); InChI=1S/C13H16FNO.ClH/c1-15-13(9-5-4-8-12(13)16)11-7-3-2-6-10(11)14/h2-3,6-7,15H,4-5,8-9H2,1H3;1H/t13-/m0/s1 provides definitive structural identification.

Chemical & Physical Characteristics

Each 100mg pellet presents as a uniform off-white to white compressed solid containing crystalline 2-FDCK HCl matrixed with inert binders, designed for complete dissolution in aqueous/organic media. The discrete unit dosage eliminates weighing variability, supporting direct transfer to volumetric flasks for stock solution preparation.

Solubility exceeds 50 mg/mL in methanol, acetonitrile, and DMSO; full dissolution achieved within 30 minutes under sonication per standard analytical protocols. Pellets maintain physical integrity under desiccated storage, with controlled release characteristics optimized for LC-MS matrix effects minimization.

Purity & Analytical Verification

≥98% purity specification meets forensic/toxicological reference standards requirements, delivering characteristic MS fragments (m/z 222 [M+H]+, 204 [M+H-NHCH3]+) and LC retention distinct from ketamine positional isomers. Supports unequivocal identification via orthogonal LC-QTOF-MS, GC-EI-MS, and 1H-NMR (CDCl3: δ 7.55-7.15 ppm aromatic, 2.45 ppm N-CH3).​

Batch analysis employs chiral HPLC (R/S enantiomeric excess >99:1 possible), HPLC-DAD (≥98% auc), Karl Fischer (<0.5% H2O), and LC-HRMS (exact mass 222.1293 Da); comprehensive spectral libraries accompany COAs.​

Quality Control & Batch Integrity

Pellet production incorporates microgram-precision fill weight control (100.0 ± 1.0 mg), tablet hardness (4-6 kp), friability (<1%), and content uniformity (RSD <2%) per USP <905> standards adapted for research materials. Lot genealogy traces API synthesis, compression parameters, and coating application for GLP traceability.​

Three-stage release testing validates potency (HPLC 98.0-102.0%), dissolution profile (>85% in 30 min, USP Apparatus 2), microbial limits, and heavy metals; retained composites support stability monitoring through 24 months.​

Safety, Handling & Laboratory Precautions

Pellet handling requires powder containment systems (glovebox/fume hood) to prevent dust generation during subdivision; PPE includes static-dissipative gloves, safety goggles, and lab coat per institutional chemical hygiene protocols.​

Disintegration products and wash solvents classified as research chemical waste per RCRA Subtitle C; incineration at 1200°C recommended; laboratory operations exclusively—no administration guidance.​

Packaging, Labeling & Storage

Individually blistered 100mg pellets in tamper-evident foil trays (10-50/pack) with desiccant overwrap and child-resistant outer container; nitrogen-flushed for oxidative stability. GHS labels specify content, CAS, lot, purity, and “Research Chemical – Not for Human Use.”​

Store desiccated at 15-25°C (excursion 2-8°C permitted); 24-month shelf life from manufacture when sealed.​

Intended Research Use & Market Positioning

100mg pellet format optimizes quantitative toxicology, PK/PD investigations, and NMDA receptor binding displacement assays requiring milligram precision without analytical balance dependency. Direct compatibility with dried blood spot (DBS) cards and quantitative NMR standards.​

Strictly laboratory research positioning excludes clinical, veterinary, therapeutic, or consumer applications. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Ordering, Availability & Fulfillment

Institutional procurement via compliant WooCommerce platform with age/ID verification and DEA watchlist screening; multi-pack discounts for bulk laboratory orders. Temperature-controlled logistics (2-8°C) with real-time tracking.​

Technical support provides batch-specific dissolution profiles, matrix effect data, and instrument method files.​

Legal & Regulatory Disclaimer

2F-Ketamine Pellets – 100mg constitute an unregistered laboratory research chemical without FDA/EMA approval for medicinal, investigational new drug, or commercial applications. Diversion to human/animal administration, clinical research, or therapeutic contexts expressly prohibited; no toxicological, pharmacological, or safety data beyond analytical specifications provided. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Purchasers affirm full jurisdictional compliance for acquisition, possession, analysis, and disposition, certifying DEA-registered laboratory status and IRB oversight where applicable.